Analytical Data
-
Gene name
ABRACL
- Application
-
Alternative Names
ABRACL；C6orf115；Costars family Protein ABRACL
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9P1F3
-
Expression Region
1-81
-
AA Sequence
MNVDHEVNLL VEEIHRLGSK NADGKLSVKF GVLFRDDKCA NLFEALVGTL KAAKRRKIVT YPGELLLQGV HDDVDIILLQ D
-
Molecular Weight
9kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ABRACL (ABRA-Cadabra-Like Protein) is an intriguing protein that has garnered attention in the fields of molecular biology and genetics due to its potential roles in cellular processes and disease mechanisms. Research has indicated that ABRACL may be implicated in crucial cellular functions such as cytoskeletal organization, cellular signaling, and the regulation of cell migration and adhesion. Its unique structure, characterized by the presence of multiple domains, suggests that it could interact with various signaling pathways, influencing cellular behavior in both normal and pathological contexts. Specifically, studies have linked ABRACL to cancer development, where aberrant expression levels may contribute to tumor progression and metastasis. Furthermore, the exploration of ABRACL's function in immune response highlights its potential as a biomarker or therapeutic target in autoimmune diseases and infections. The recombinant expression of ABRACL provides a valuable tool for researchers aiming to elucidate its functional mechanisms and interactions within cellular systems. As our understanding of this protein deepens, it may pave the way for novel strategies in disease treatment and prevention, making ABRACL a significant focus of ongoing biomedical research.
